03:46 AM EDT, 08/28/2025 (MT Newswires) -- Cognition Therapeutics ( CGTX ) said late Wednesday it has agreed to sell 14.7 million common shares in a registered direct offering for expected gross proceeds of $30 million.

"The offering was made to two new fundamental institutional investors, including a preeminent global investment manager," the company said.

Net proceeds will be used for clinical development, working capital and general corporate purposes.

Closing of the offering is expected on Friday, subject to customary conditions.